Cargando…

Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens

Four forms of cytochrome P‐450 were separated and purified to electrophoretic homogeneity from human fetal livers. These forms of cytochrome P‐450, termed P‐450HFLa, P‐450HFLb, P‐450HFLc and P‐450HFLd, were distinguishable from each other in their molecular weights, spectral properties, immunochemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitada, Mitsukazu, Taneda, Masaki, Itahashi, Koshiro, Kamataki, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918441/
https://www.ncbi.nlm.nih.gov/pubmed/1904422
http://dx.doi.org/10.1111/j.1349-7006.1991.tb01866.x
_version_ 1783317416893218816
author Kitada, Mitsukazu
Taneda, Masaki
Itahashi, Koshiro
Kamataki, Tetsuya
author_facet Kitada, Mitsukazu
Taneda, Masaki
Itahashi, Koshiro
Kamataki, Tetsuya
author_sort Kitada, Mitsukazu
collection PubMed
description Four forms of cytochrome P‐450 were separated and purified to electrophoretic homogeneity from human fetal livers. These forms of cytochrome P‐450, termed P‐450HFLa, P‐450HFLb, P‐450HFLc and P‐450HFLd, were distinguishable from each other in their molecular weights, spectral properties, immunochemical properties and mutagen‐producing activities from promntagens. The molecular weights of P‐450HFLa, b, c and d were estimated to be 51,500, 49,000, 51,500 and 50,000, respectively. Antibodies to P‐450HFLa recognized P‐450HFLc but not P‐450HFLb or d, and antibodies to rat P‐448‐H (P‐450IA2) cross‐reacted with P‐450HFLb but not with other forms of cytochrome P‐450. The N‐terminal amino acid sequence of P‐450HFLc was highly homologous, but not identical, to that of P‐450HFLa. Each form of cytochrome P‐450 catalyzed mutagenic activation of aflatoxin Bl (AFB1), 2‐amino‐3‐methylimidazo[4,5‐f]quinoline (IQ) and 2‐amino‐6‐methyldipyrido‐[l,2‐a:3′,2′‐d]imidazole (Glu‐P‐1) at different rates. P‐450 HFLa showed activities to produce mutagen(s) from AFB1, IQ and to a lesser extent from Glu‐P‐1. P‐450 HFLb activated IQ at a faster rate than did the other forms. P‐450 HFLc produced a mutagen from AFB1 and Glu‐P‐1 but not from IQ. P‐450 HFLd did not activate these promutagens at significant rates.
format Online
Article
Text
id pubmed-5918441
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59184412018-05-11 Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens Kitada, Mitsukazu Taneda, Masaki Itahashi, Koshiro Kamataki, Tetsuya Jpn J Cancer Res Article Four forms of cytochrome P‐450 were separated and purified to electrophoretic homogeneity from human fetal livers. These forms of cytochrome P‐450, termed P‐450HFLa, P‐450HFLb, P‐450HFLc and P‐450HFLd, were distinguishable from each other in their molecular weights, spectral properties, immunochemical properties and mutagen‐producing activities from promntagens. The molecular weights of P‐450HFLa, b, c and d were estimated to be 51,500, 49,000, 51,500 and 50,000, respectively. Antibodies to P‐450HFLa recognized P‐450HFLc but not P‐450HFLb or d, and antibodies to rat P‐448‐H (P‐450IA2) cross‐reacted with P‐450HFLb but not with other forms of cytochrome P‐450. The N‐terminal amino acid sequence of P‐450HFLc was highly homologous, but not identical, to that of P‐450HFLa. Each form of cytochrome P‐450 catalyzed mutagenic activation of aflatoxin Bl (AFB1), 2‐amino‐3‐methylimidazo[4,5‐f]quinoline (IQ) and 2‐amino‐6‐methyldipyrido‐[l,2‐a:3′,2′‐d]imidazole (Glu‐P‐1) at different rates. P‐450 HFLa showed activities to produce mutagen(s) from AFB1, IQ and to a lesser extent from Glu‐P‐1. P‐450 HFLb activated IQ at a faster rate than did the other forms. P‐450 HFLc produced a mutagen from AFB1 and Glu‐P‐1 but not from IQ. P‐450 HFLd did not activate these promutagens at significant rates. Blackwell Publishing Ltd 1991-04 /pmc/articles/PMC5918441/ /pubmed/1904422 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01866.x Text en
spellingShingle Article
Kitada, Mitsukazu
Taneda, Masaki
Itahashi, Koshiro
Kamataki, Tetsuya
Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens
title Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens
title_full Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens
title_fullStr Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens
title_full_unstemmed Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens
title_short Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens
title_sort four forms of cytochrome p‐450 in human fetal liver: purification and their capacity to activate promutagens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918441/
https://www.ncbi.nlm.nih.gov/pubmed/1904422
http://dx.doi.org/10.1111/j.1349-7006.1991.tb01866.x
work_keys_str_mv AT kitadamitsukazu fourformsofcytochromep450inhumanfetalliverpurificationandtheircapacitytoactivatepromutagens
AT tanedamasaki fourformsofcytochromep450inhumanfetalliverpurificationandtheircapacitytoactivatepromutagens
AT itahashikoshiro fourformsofcytochromep450inhumanfetalliverpurificationandtheircapacitytoactivatepromutagens
AT kamatakitetsuya fourformsofcytochromep450inhumanfetalliverpurificationandtheircapacitytoactivatepromutagens